WASHINGTON (MedPage Today) — New grants totaling $320 million and aimed at bolstering the primary care work force will include funds to train an additional 900 physicians over the next three years, Health and Human Service (HHS) Secretary Kathleen Sebelius announced on Tuesday.
No Comments »
Filed under: General Health News
(MedPage Today) — The 2009 pandemic H1N1 influenza virus will likely disappear unless it mutates to avoid high global immunity, researchers speculated.
No Comments »
Filed under: General Health News
(MedPage Today) — Increasing the taxes assessed on alcohol could have significant public health benefits, including lower alcohol-related mortality and reductions in traffic fatalities, a meta-analysis determined.
No Comments »
Filed under: General Health News
(MedPage Today) — Certain lots of epoetin alfa (Epogen and Procrit) — used to treat anemia related to HIV therapy, chronic renal failure, and chemotherapy — were voluntarily recalled due to the presence of thin, barely-visible glass flakes in the solution which could cause adverse events.
No Comments »
Filed under: General Health News
(MedPage Today) — A phase IIIa trial of the tyrosine kinase inhibitor sunitinib (Sutent) in patients with advanced castration-resistant prostate cancer has been halted for lack of efficacy, the drug’s manufacturer announced.
No Comments »
Filed under: Pharmacy News
(MedPage Today) — Certain lots of epoetin alfa (Epogen and Procrit) — used to treat anemia related to HIV therapy, chronic renal failure, and chemotherapy — were voluntarily recalled due to the presence of thin, barely-visible glass flakes in the solution which could cause adverse events.
No Comments »
Filed under: Pharmacy News
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 2 clinical trial in Canada with its novel defensin-mimetic antibiotic, PMX-30063.
No Comments »
Filed under: Pharmacy News
Galapagos NV announced today that it has started a Phase II clinical study for the Company’s flagship program GLPG0259, a novel drug being developed for rheumatoid arthritis. In this clinical trial, the safety and efficacy of this novel candidate drug will be tested in RA patients. Galapagos plans to announce interim results by the middle [...]
No Comments »
Filed under: Pharmacy News
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that their eSensor Warfarin Sensitivity Test has been selected for use in a new pivotal Warfarin clinical study the WARFARIN Trial.
No Comments »
Filed under: Pharmacy News
Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic low back pain have been published online by Expert Opinion on Pharmacotherapy. In addition, this study compared oxycodone controlled-release (CR) to placebo as an active control.
No Comments »
Filed under: Pharmacy News
